PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
AboutPricing
Disease ReportsLymphoma
MeSH D008223 - lymphoma
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
See list view
D009370:Neoplasms by histologic type
0 Companies
0 Drugs
Success rate
D008232:Lymphoproliferative disorders
2 Companies
2 Drugs
$
Success rate
D008223: 
Lymphoma
79 Companies
11 Drugs
$
Success rate
D006689:Hodgkin disease
57 Companies
21 Drugs
$
Success rate
D007161:Immunoproliferative small intestinal disease
0 Companies
0 Drugs
Success rate
D008228:Non-hodgkin lymphoma
58 Companies
24 Drugs
$
Success rate
D058617:Composite lymphoma
0 Companies
0 Drugs
Success rate
D064090:Intraocular lymphoma
0 Companies
0 Drugs
Success rate
Events Timeline
Loading
Commercial
Company Name
Drug Name
Trade Name
Patent Expires
Approval Date
Revenue
Period
A.H. Robins CompanyPrednisone Prednisone  1982-01-01   
Accord HealthcareIrinotecan Irinotecan  2008-11-21   
AdienneThiotepa Tepadina  2017-01-26   
AllerganPrednisone Prednisone  1982-01-01   
Irinotecan Irinotecan  2008-02-27   
American TherapeuticsPrednisone Prednisone  1986-11-06   
Amneal PharmaceuticalsPrednisone Prednisone  1987-10-05   
Aurobindo PharmaPrednisone Prednisone  2021-11-16   
Bausch Health CompaniesPrednisone Prednisone  1982-01-01   
BayerPrednisone Deltome  1982-01-01   
BelotecaThiotepa Thiotepa  2021-12-08   
1
2
3
4
5
6
...
8
>
Clinical Trials
Historical Success Rate
Phase 1
74%
193/262
Phase 2
40%
118/293
Phase 3
18%
32/173
Approved: 10Overall Success rate: 5%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name
Phase 1
Phase 2
Phase 3
Phase 4
Drug Name
Adienne
Thiotepa,
Hsct,
Bolus
Bausch Health Companies
Prednisone,
Corticoids
Bayer
Prednisone,
Tbo-filgrastim,
Antithrombin iii,
Cilmostim,
Aglatimagene besadenovec,
Lenograstim,
Ademetionine,
Calcium dobesilate,
Doconexent,
Regramostim,
Molgramostim,
ELIMUSERTIB,
Sodium chloride,
Sodium lactate,
Aspartame,
Bevifimod,
BIMIRALISIB,
ORTATAXEL,
Palifosfamide,
Microcrystalline cellulose,
Bay1862864,
Bay806946,
Caelyx,
Doxorubin,
Iphosphamid,
Allograft,
Vp16,
Gcsf,
Sagramostim,
Solumedrol,
Hsct,
Arm1,
Beam,
Hydroxydaunomycin,
Arm2,
Bolus,
Rchop,
Taxane,
Evidence,
Abt199
Bristol Myers Squibb
Nivolumab,
Relatlimab,
Transplatin,
Tbo-filgrastim,
Antithrombin iii,
Bempegaldesleukin,
Cilmostim,
Enoblituzumab,
Epacadostat,
Veliparib,
Lenograstim,
Calcium dobesilate,
Doconexent,
Imgatuzumab,
Serine,
Sodium lactate,
AVADOMIDE,
Bevifimod,
CABIRALIZUMAB,
IRATUMUMAB,
LIRILUMAB,
OSUGACESTAT,
Palifosfamide,
URELUMAB,
Veltuzumab,
Microcrystalline cellulose,
BMS-906024,
Caelyx,
Fendrix,
Doxorubin,
Ibi301,
Iphosphamid,
Mk3475,
Q2w,
Vp16,
Abvd,
Gcsf,
Gemox,
Solumedrol,
Hsct,
Arm1,
Gdp,
Hydroxydaunomycin,
Bolus,
Cc5013,
Cmab819,
Evidence,
Abt199,
Tqb2303
1
2
3
4
5
6
>
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use